Ingevity Corporation NGVT
$68.25
-$1.16-1.67%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -5.25% | 4.07% | -3.11% | -0.21% | 26.09% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.25% | 4.07% | -3.11% | -0.21% | 26.09% |
| Cost of Revenue | -14.04% | 4.12% | 6.49% | -1.48% | 57.54% |
| Gross Profit | 8.76% | 4.02% | -17.33% | 1.75% | -4.34% |
| SG&A Expenses | -10.55% | -2.86% | 8.90% | 16.36% | 26.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.41% | 2.22% | 7.19% | 1.62% | 51.19% |
| Operating Income | 21.63% | 9.52% | -36.91% | -5.37% | -18.48% |
| Income Before Tax | 137.12% | -19.68% | -536.93% | 15.19% | 6.88% |
| Income Tax Expenses | 127.08% | -20.00% | -688.89% | 229.23% | 133.80% |
| Earnings from Continuing Operations | 128.15% | -19.59% | -502.04% | -14.11% | -6.72% |
| Earnings from Discontinued Operations | 11.76% | 523.26% | -93.33% | 101.75% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 124.10% | 191.71% | -609.64% | 140.58% | 48.36% |
| EBIT | 21.63% | 9.52% | -36.91% | -5.37% | -18.48% |
| EBITDA | 12.55% | 2.84% | -23.18% | -4.66% | -16.39% |
| EPS Basic | 125.33% | 200.99% | -615.49% | 140.62% | 48.58% |
| Normalized Basic EPS | 37.49% | 30.50% | -96.40% | -1.28% | -41.46% |
| EPS Diluted | 124.95% | 198.99% | -616.10% | 139.91% | 48.58% |
| Normalized Diluted EPS | 35.19% | 28.74% | -96.40% | -2.61% | -41.46% |
| Average Basic Shares Outstanding | -4.86% | -3.09% | -1.72% | -0.10% | 0.44% |
| Average Diluted Shares Outstanding | -3.24% | -1.76% | -1.72% | 1.27% | 0.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |